日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

SAMHD1 表达和突变状态对套细胞淋巴瘤的影响:对 MCL 青年和老年试验的分析

Tobias Roider, Xi Wang, Katrin Hüttl, Carsten Müller-Tidow, Wolfram Klapper, Andreas Rosenwald, James Peter Stewart, David Gonzalez de Castro, Peter Dreger, Olivier Hermine, Hanneke C Kluin-Nelemans, Niels Grabe, Martin Dreyling, Christiane Pott, German Ott, Eva Hoster, Sascha Dietrich

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance

对伊马替尼疗法有反应和无反应的初治慢性粒细胞白血病患者之间的 miR-142-5p 表达差异表明与致癌 ABL2、SRI、cKIT 和 MCL1 信号通路有关,这些通路对于治疗耐药性的产生至关重要

Theresa Klümper #, Henrike Bruckmueller #, Tobias Diewock, Meike Kaehler, Sierk Haenisch, Christiane Pott, Oliver Bruhn, Ingolf Cascorbi